abrdn Life Sciences Investors

HQL · NYSE

$17.73−$0.22 (−1.23%)TodayMarket closed ·
Prev close $17.95

About HQL

abrdn Life Sciences Investors is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in equity and related securities of the United States and foreign companies principally engaged in the development, production or distribution of products or services related to scientific advances in life sciences (including biotechnology, pharmaceuticals, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices, supplies and other healthcare-related sub-sectors), agriculture and environmental management (Life Sciences Companies). The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.

Employees
0
Headquarters
PHILADELPHIA, Pennsylvania
Listed
May 1, 1992
Sector
N/A
Industry
N/A

HQL key statistics

Market cap
544.91M
Price-earnings ratio
0.00
Dividend yield
6.06%
Average volume
129.25K
Volume
60.80K
Open price
$17.99
High today
$17.99
Low today
$17.51
52 Week high
$22.67
52 Week low
$15.66

abrdn Life Sciences Investors (HQL) at a glance

abrdn Life Sciences Investors (HQL) last traded at $17.73, with a market cap of 544.91M, a price-to-earnings ratio of 0.00 and a dividend yield of 6.06%.

Today the stock has traded between $17.51 and $17.99. The current price is 1.3% above the day's low and 1.4% below its high.

Volume so far is 60.80K shares, below the average of 129.25K shares a day.

Over the past year abrdn Life Sciences Investors has ranged from $15.66 to $22.67, and now sits 30% of the way up that range.

HQL news

  • Press releasePRNewswire

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

  • Press releasePRNewswire

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

  • Press releasePRNewswire

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

  • Press releasePRNewswire

    ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

  • Press releasePRNewswire

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

  • Press releasePRNewswire

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

  • Press releasePRNewswire

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

  • Press releasePRNewswire

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.